Hepatitis B and C among healthcare workers and patient groups at increased risk of iatrogenic transmission in the European Union/European Economic Area
Tavoschi, L., Mason, L., Petriti, U., Bunge, E., Veldhuijzen, I., Duffell, E.
Hepatitis b and c prevalence and incidence in key population groups with multiple risk factors in the EU/ EEA: A systematic review
Mason, L.M.K., Duffell, E., Veldhuijzen, I.K., Petriti, U., Bunge, E.M., Tavoschi, L.
Health risks during the Carnival season in Brazil
The Carnival season will last from 1 to 9 March 2019. In Rio de Janeiro, Brazil, 1 million participants are expected, including many travellers from Europe
Can economic indicators predict infectious disease spread? A cross-country panel analysis of 13 European countries
Hunter, P.R., Colón-González, F.J., Brainard, J., Majuru, B., Pedrazzoli, D., Abubakar, I., Dinsa, G., Suhrcke, M., Stuckler, D., Lim, T.-A., Semenza, J.C.
Active Case Finding for Communicable Diseases in Prison Settings: Increasing Testing Coverage and Uptake among the Prison Population in the European Union/European Economic Area
Tavoschi, L., Vroling, H., Madeddu, G., Babudieri, S., Monarca, R., Vonk Noordegraaf-Schouten, M., Beer, N., Dias, J.G., O'Moore, É., Hedrich, D., Oordt-Speets, A.
Key dimensions for the prevention and control of communicable diseases in institutional settings: A scoping review to guide the development of a tool to strengthen preparedness at migrant holding centres in the EU/EEA
Riccardo, F., Suk, J.E., Espinosa, L., Bella, A., Giambi, C., Delmanso, M., Napoli, C., Grazia Dente, M., Nacca, G., Declich, S.
People living with undiagnosed HIV infection and a low CD4 count: Estimates from surveillance data, Italy, 2012 to 2014
Regine, V., Dorrucci, M., Pezzotti, P., Mammone, A., Quinten, C., Pharris, A., Suligoi, B., Di Giacomo, M., Faggioni, V., Scancella, L., Locuratolo, F., Cauzillo, G., Mignuoli, A.D., Chirico, D.G., Borgia, G., Massimiliani, E., Gallo, T., Braida, C., Puro, V., Scognamiglio, P., Icardi, G., Lai, P.L., Gramegna, M., Coppola, L., Piatti, A., Rosa, A., Cereda, D., Filippetti, F., Prozzo, A., Pasqualini, C., Mian, P., Moling, O., Pagani, L., Lanzafame, P., Collini, L., Bassetti, D., Chironna, M., Palmas, M.A., Dardanoni, G., Voller, F., Puglia, M., Pecori, L., Tosti, A., Papili, R., Ruffier, M., Verardo, M.G., Echarlod, E.F., Amoroso, S., Russo, F., Da Re, F.
Effectiveness and cost-effectiveness of antenatal screening for HIV, hepatitis B, syphilis and rubella susceptibility
This literature review was conducted as part of a project evaluating the effectiveness of antenatal screening for HIV, hepatitis B, syphilis and rubella susceptibility in EU/EEA Member States.
Antenatal screening approaches effective in preventing MTCT of HIV, HBV, syphilis and rubella in vulnerable populations
In order to collect evidence on effective types of antenatal screening intervention that are effective for population groups vulnerable to MTCT, a review of the existing published literature was performed.
Public health guidance on antenatal screening for HIV, hepatitis B, syphilis and rubella susceptibility in the EU/EEA – addressing the vulnerable populations
This publication aims to support the strengthening of antenatal screening programmes for HIV, hepatitis B, syphilis and rubella susceptibility in the general population and in groups identified as vulnerable to mother-to-child-transmission in the EU/EEA.